Skip to main content
[Preprint]. 2024 Mar 28:rs.3.rs-4004555. [Version 1] doi: 10.21203/rs.3.rs-4004555/v1

Table 4.

Outcomes of the study population

Characteristic Self-monitored Peer-supported Clinically integrated Total
n (M, SD) n (M, SD) n (M, SD) n (M, SD)
Percentage of risky drinking days, PRDD
Baseline 185 (37.1, 30.6) 186 (36.2, 31.2) 186 (41.9, 31.4) 557 (38.4, 31.1)
3 Months 178 (25.5, 28.2) 178 (23.8, 30.1) 162 (29.4, 28.2) 518 (26.1, 28.9)
6 Months 161 (23.6, 27.3) 162 (24.3, 30.1) 139 (25.3, 31.2) 462 (24.4, 29.4)
9 Months 145 (20.3, 24.6) 145 (21.2, 27.7) 109 (22.4, 27.4) 399 (21.2, 26.5)
12 Months 139 (24.4, 28.2) 130 (21.4, 28.9) 100 (21.3, 30.4) 369 (22.5, 29)
ARR or RRR* −12.7 or −34.2% −14.8 or −40.9% −20.6 or −49.2% −15.9 or −41.4%
Quality of Life - Physical Health, QOL-PH *
Baseline 185 (48.4, 6.3) 186 (48.1, 6.7) 186 (48.3, 6.5) 557 (48.3, 6.5)
3 Months 178 (48.6, 6.6) 177 (48.4, 6.6) 162 (47.8, 6.7) 517 (48.3, 6.6)
6 Months 161 (48.6, 6.4) 162 (48.7, 7.2) 139 (48.1, 7.2) 462 (48.5, 6.9)
9 Months 145 (48.5, 6.3) 145 (49.6, 6.1) 109 (48.1, 7.4) 399 (48.8, 6.6)
12 Months 139 (48.6, 6.8) 130 (49.3, 6.4) 100 (48.1, 7.5) 369 (48.6, 6.9)
ARR or RRR* −0.2 or 0.4% 1.2 or 2.5% −0.2 or −0.4% 0.3 or 0.6%
Quality of Life - Mental Health, QOL-MH *
Baseline 185 (45.5, 6.9) 186 (45,5, 7.5) 186 (45.4, 6.9) 557 (45.4, 7.1)
3 Months 178 (46.3, 7) 177 (45,9, 7.3) 162 (47.3, 7.1) 517 (46.5, 7.1)
6 Months 161 (46.4, 7.1) 162 (47.4, 7.5) 139 (48, 7.5) 462 (47.2, 7.4)
9 Months 145 (46.4, 7.2) 145 (47.3, 7.2) 109 (48.1, 7.2) 399 (47.2, 7.2)
12 Months 139 (46.7, 8.3) 130 (47.7, 8.3) 100 (48.1, 7) 369 (47.4, 8)
ARR or RRR** 1.2, 2.6% 2.2, 4.8% 2.7, 5.9% 1.8, 4%

Notes: Abbreviations: M: Mean, SD: Standard Deviation, n: Sample size, ARR: Absolute Risk Reduction, RRR: Relative Risk Reduction.

*

QOL measures are T-scores.

**

ARR and RRR were calculated between values in baseline and 12 months.